| UniProt ID | GBRA5_HUMAN | |
|---|---|---|
| UniProt AC | P31644 | |
| Protein Name | Gamma-aminobutyric acid receptor subunit alpha-5 | |
| Gene Name | GABRA5 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 462 | |
| Subcellular Localization |
Cell junction, synapse, postsynaptic cell membrane Multi-pass membrane protein. Cell membrane Multi-pass membrane protein. |
|
| Protein Description | GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel.. | |
| Protein Sequence | MDNGMFSGFIMIKNLLLFCISMNLSSHFGFSQMPTSSVKDETNDNITIFTRILDGLLDGYDNRLRPGLGERITQVRTDIYVTSFGPVSDTEMEYTIDVFFRQSWKDERLRFKGPMQRLPLNNLLASKIWTPDTFFHNGKKSIAHNMTTPNKLLRLEDDGTLLYTMRLTISAECPMQLEDFPMDAHACPLKFGSYAYPNSEVVYVWTNGSTKSVVVAEDGSRLNQYHLMGQTVGTENISTSTGEYTIMTAHFHLKRKIGYFVIQTYLPCIMTVILSQVSFWLNRESVPARTVFGVTTVLTMTTLSISARNSLPKVAYATAMDWFIAVCYAFVFSALIEFATVNYFTKRGWAWDGKKALEAAKIKKKREVILNKSTNAFTTGKMSHPPNIPKEQTPAGTSNTTSVSVKPSEEKTSESKKTYNSISKIDKMSRIVFPVLFGTFNLVYWATYLNREPVIKGAASPK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 45 | N-linked_Glycosylation | VKDETNDNITIFTRI CCCCCCCCEEHHHHH | 35.06 | UniProtKB CARBOHYD | |
| 126 | Phosphorylation | PLNNLLASKIWTPDT CHHHHHHHCCCCCCC | 25.33 | 27251275 | |
| 133 | Phosphorylation | SKIWTPDTFFHNGKK HCCCCCCCCCCCCCC | 29.42 | 27251275 | |
| 145 | N-linked_Glycosylation | GKKSIAHNMTTPNKL CCCCCCCCCCCCCCE | 22.07 | UniProtKB CARBOHYD | |
| 207 | N-linked_Glycosylation | EVVYVWTNGSTKSVV EEEEEEECCCCCEEE | 27.06 | UniProtKB CARBOHYD | |
| 236 | N-linked_Glycosylation | GQTVGTENISTSTGE CCEECCCCCCCCCCC | 33.09 | UniProtKB CARBOHYD | |
| 285 | Phosphorylation | SFWLNRESVPARTVF HHHHCCCCCCHHHCC | 30.11 | - | |
| 354 | Ubiquitination | RGWAWDGKKALEAAK CCCCCCHHHHHHHHH | 32.19 | 22817900 | |
| 355 | Ubiquitination | GWAWDGKKALEAAKI CCCCCHHHHHHHHHC | 64.83 | 22817900 | |
| 372 | Ubiquitination | KREVILNKSTNAFTT CCEEEEECCCCCCCC | 56.03 | 33845483 | |
| 373 | Phosphorylation | REVILNKSTNAFTTG CEEEEECCCCCCCCC | 26.31 | 22210691 | |
| 378 | Phosphorylation | NKSTNAFTTGKMSHP ECCCCCCCCCCCCCC | 32.03 | 22210691 | |
| 404 | Phosphorylation | TSNTTSVSVKPSEEK CCCCCEEEECCCCCC | 24.96 | 22210691 | |
| 406 | Ubiquitination | NTTSVSVKPSEEKTS CCCEEEECCCCCCCC | 35.01 | 33845483 | |
| 411 | Ubiquitination | SVKPSEEKTSESKKT EECCCCCCCCCCHHH | 53.98 | - | |
| 418 | Phosphorylation | KTSESKKTYNSISKI CCCCCHHHHHHHHHH | 31.50 | 23403867 | |
| 419 | Phosphorylation | TSESKKTYNSISKID CCCCHHHHHHHHHHH | 18.78 | 23403867 | |
| 421 | Phosphorylation | ESKKTYNSISKIDKM CCHHHHHHHHHHHHH | 20.16 | 23403867 | |
| 423 | Phosphorylation | KKTYNSISKIDKMSR HHHHHHHHHHHHHHH | 24.31 | 23403867 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GBRA5_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GBRA5_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GBRA5_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of GBRA5_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| D00058 | Gamma-Aminobutyric acid (JAN); Gammalon (TN) | |||||
| D00225 | Alprazolam (JP16/USP/INN); Xanax (TN) | |||||
| D00267 | Chlordiazepoxide (JP16/USP/INN); Libritabs (TN) | |||||
| D00280 | Clonazepam (JP16/USP/INN); Klonopin (TN) | |||||
| D00293 | Diazepam (JP16/USP/INN); Diastat (TN); Valium (TN) | |||||
| D00311 | Estazolam (JP16/USAN/INN); ProSom (TN) | |||||
| D00329 | Flurazepam (JAN/INN); Insumin (TN) | |||||
| D00331 | Furosemide (JP16/USP/INN); Frusemide; Lasix (TN) | |||||
| D00365 | Lorazepam (JP16/USP/INN); Ativan (TN) | |||||
| D00370 | Temazepam (USP/INN); Restoril (TN) | |||||
| D00376 | Meprobamate (JAN/USP/INN); Equanil (TN); Miltown (TN) | |||||
| D00387 | Triazolam (JAN/USP/INN); Halcion (TN) | |||||
| D00430 | Secobarbital (USP/INN); Seconal (TN) | |||||
| D00457 | Quazepam (JAN/USP/INN); Doral (TN) | |||||
| D00470 | Prazepam (JP16/USAN/INN); Centrax (TN) | |||||
| D00499 | Pentobarbital (USP/INN); Nembutal (TN) | |||||
| D00500 | Pentobarbital sodium (JAN/USP); Nembutal sodium (TN) | |||||
| D00506 | Phenobarbital (JP16/USP/INN); Luminal (TN) | |||||
| D00531 | Nitrazepam (JP16/USAN/INN); Benzalin (TN); Nitrazepam (TN) | |||||
| D00532 | Glutethimide (JAN/INN); Doriden (TN) | |||||
| D00549 | Propofol (JAN/USAN/INN); Diprivan (TN) | |||||
| D00550 | Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN) | |||||
| D00555 | Amobarbital (JP16/INN); Isomytal (TN) | |||||
| D00557 | Methaqualone (JAN/USAN/INN) | |||||
| D00693 | Chlordiazepoxide hydrochloride (JAN/USP); Librium (TN) | |||||
| D00694 | Clorazepate dipotassium (JP16/USP); Tranxene (TN) | |||||
| D00695 | Flurazepam hydrochloride (USP); Flurazepam dihydrochloride; Dalmane (TN) | |||||
| D00696 | Midazolam hydrochloride (USAN); Versed (TN) | |||||
| D00697 | Flumazenil (JAN/USP/INN); Romazicon (TN) | |||||
| D00700 | Mephobarbital (JAN/USP); Methylphenobarbital (INN); Mebaral (TN) | |||||
| D00701 | Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) | |||||
| D00706 | Zolpidem tartrate (JP16/USAN); Ambien (TN); Intermezzo (TN) | |||||
| D00713 | Thiamylal sodium (JP16); Surital (TN) | |||||
| D00714 | Thiopental sodium (JP16/USP/INN); Pentothal (TN) | |||||
| D01071 | Hexobarbital (JAN/INN) | |||||
| D01230 | Flunitrazepam (JP16/USAN/INN); Rohypnol (TN) | |||||
| D01245 | Bromazepam (JP16/USAN/INN); Lectopam (TN) | |||||
| D01253 | Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) | |||||
| D01254 | Tofisopam (JP16/INN); Emandaxin (TN) | |||||
| D01268 | Cloxazolam (JP16/INN); Sepazon (TN) | |||||
| D01278 | Oxazolam (JP16/INN); Serenal (TN) | |||||
| D01279 | Flutoprazepam (JP16/INN); Restas (TN) | |||||
| D01286 | Flutazolam (JAN/INN); Coreminal (TN) | |||||
| D01292 | Medazepam (JP16/INN); Pamnace (TN) | |||||
| D01293 | Ethyl loflazepate (JAN/INN); Meilax (TN) | |||||
| D01310 | Secobarbital sodium (JAN/USP); Seconal sodium (TN) | |||||
| D01316 | Mexazolam (JAN/INN); Melex (TN) | |||||
| D01328 | Clotiazepam (JP16/INN); Rize (TN) | |||||
| D01354 | Fludiazepam (JP16/INN); Erispan (TN) | |||||
| D01372 | Zopiclone (JAN/INN); Amoban (TN); Zopiclone (TN) | |||||
| D01408 | Flurazepam hydrochloride (JP16); Flurazepam monohydrochloride; Dalmate (TN) | |||||
| D01514 | Etizolam (JP16/INN); Sedekopan (TN) | |||||
| D01564 | Rilmazafone hydrochloride hydrate (JAN); Rilmazafone hydrochloride dihydrate; Rilmazafone hydrochlor | |||||
| D01593 | Nimetazepam (JAN/INN); Erimin (TN) | |||||
| D01657 | Lormetazepam (JAN/USAN/INN); Loramet (TN) | |||||
| D01740 | Barbital (JP16/INN); Barbital (TN) | |||||
| D01744 | Brotizolam (JP16/USAN/INN); Lendormin (TN) | |||||
| D01758 | Haloxazolam (JP16/INN); Somelin (TN) | |||||
| D02252 | Amobarbital sodium (JAN/USP); Amytal sodium (TN) | |||||
| D02253 | Pentobarbital calcium (JP16); Ravona (TN) | |||||
| D02283 | Iomazenil (123I) (JAN/INN); Benzodine (TN) | |||||
| D02594 | Abecarnil (INN) | |||||
| D02616 | Pagoclone (USAN/INN); Bextra (TN) | |||||
| D02617 | Ocinaplon (USAN/INN) | |||||
| D02624 | Eszopiclone (JAN/USAN/INN); Estorra (TN); Lunesta (TN) | |||||
| D02833 | Alpidem (USAN/INN) | |||||
| D03155 | Bretazenil (USAN/INN) | |||||
| D03562 | Clorazepate monopotassium (USAN) | |||||
| D03737 | Dextofisopam (USAN/INN) | |||||
| D04257 | Fospropofol disodium (USAN); Aquavan (TN); Lusedra (TN) | |||||
| D04282 | Gaboxadol (USAN/INN) | |||||
| D04300 | Ganaxolone (USAN/INN) | |||||
| D04721 | Levotofisopam (USAN/INN) | |||||
| D04882 | Medazepam hydrochloride (USAN); Nobrium (TN) | |||||
| D05028 | Midazolam maleate (USAN) | |||||
| D06106 | Thiamylal | |||||
| D07326 | Loprazolam (INN); Dormonoct (TN) | |||||
| D07409 | Pentetrazol (INN); Pentylenetetrazol; Coryvet [veterinary] (TN) | |||||
| D07784 | Delorazepam (INN); Dadumir (TN) | |||||
| D07999 | Sodium furosemide; Frosemide sodium; Lasix (TN) | |||||
| D08001 | Furosemide diolamine; Furosemide diethanolamine salt; Nuriban (TN) | |||||
| D08145 | Loprazolam mesilate; Loprazolam mesylate; Loprazolam methanesulfonate; Havlane (TN) | |||||
| D08283 | Nordazepam (INN); Calmday (TN) | |||||
| D08356 | Phenobarbital diethylamine; Gratusminal (TN) | |||||
| D08481 | Rilmazafone (INN) | |||||
| D08507 | Sarmazenil (INN); Sarmazol [veterinary] (TN) | |||||
| D08690 | Zolpidem (INN); Sanval (TN) | |||||
| D08840 | Adipiplon (USAN) | |||||
| D10194 | Remimazolam besilate (JAN) | |||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Ubiquitylation | |
| Reference | PubMed |
| "Tryptic digestion of ubiquitin standards reveals an improved strategyfor identifying ubiquitinated proteins by mass spectrometry."; Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.; Proteomics 7:868-874(2007). Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-355, AND MASSSPECTROMETRY. | |